alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Import Alert: Newcastle Disease Restrictions for Avian Commodities Originating from or 

Transiting Through the Canton of Jura, Switzerland

Issuance Date: March 23, 2022

Effective date: March 14, 2022

Effective immediately, and until further notice, the U.S. Department of Agriculture’s Animal and 

Plant Health Inspection Service (APHIS) Veterinary Services (VS) is adding the Canton of Jura, 

in Switzerland, to the list of countries APHIS considers affected with Newcastle disease. All 

avian, including hatching eggs, from the Canton of Jura, will be required to go through a 30-day 

quarantine upon U.S. arrival. The type of quarantine (federal, private, or home) may vary, but 

must be specified on the import permit. Except for the Cantons of Zürich and Jura, all other 

Cantons in Switzerland are considered free from Newcastle disease; avian hatching eggs from 

those areas may be imported without 30-day quarantine. All other avian types would be required 

to enter 30 days of quarantine.

Fresh, unprocessed shell/table eggs, and other egg products void of the shell (i.e., liquid eggs, 

dried egg whites) originating from or transiting through the Canton of Jura, imported as cargo, 

are prohibited unless they are accompanied by an appropriate APHIS table egg certification. 

Processed avian products and byproducts for personal use, including egg/egg products, which 

originated from or transited through the Canton of Jura, in passenger baggage must: 

­ Have a thoroughly cooked appearance.

­ Be shelf-stable as a result of APHIS-approved packaging and cooking (i.e., packaged in 

hermetically sealed containers and cooked by a commercial method after such packing to 

produce articles that are shelf-stable without refrigeration); and

­ Be accompanied by an APHIS import permit and/or government certification confirming 

that the products/byproducts were treated according to APHIS requirements. 

Unprocessed edible avian products and byproducts, including hunter-harvested meat, originating 

from or transiting through the Canton of Jura will not be permitted to enter the United States.

Processed edible avian products and byproducts originating from or transiting through the 

Canton of Jura, imported as cargo, must be accompanied by an APHIS import permit and/or 

government certification confirming that the products/byproducts were treated according to 

APHIS requirements.

Inedible avian commodities (other than hunting trophies) from the Canton of Jura must have a 

VS import permit as part of the entry documentation. Hunting trophies must be consigned to an 

APHIS-approved taxidermy establishment.

These restrictions will be updated as additional epidemiological information is obtained. Current 

information is available on the APHIS website.
#### UNITED STATES of America, Plaintiff-Appellee, v. Oscar Luis GARCIA, also known as Alvaro Duran-Lopez, also known as Jesus Renteria, Defendant-Appellant.

No. 05-50276.

Conference Calendar.

United States Court of Appeals, Fifth Circuit.

Decided Aug. 17, 2005.

Joseph H. Gay, Jr, Assistant U.S. Attorney, U.S. Attorney’s Office, Western Dis*69trict of Texas, San Antonio, TX, for Plaintiff-Appellee.

Judy Fulmer Madewell, Federal Public Defender’s Office, Western District of Texas, San Antonio, TX, for Defendant-Appellant.

Before BENAVIDES, CLEMENT, and PRADO, Circuit Judges.

PER CURIAM: *

Appealing the Judgment in a Criminal Case, Oscar Luis Garcia raises arguments that are foreclosed by *Almendarez-Torres v. United States, 523*U.S. 224, 235, 118 S.Ct. 1219, 140 L.Ed.2d 350 (1998), which held that a prior conviction is a sentencing factor under 8 U.S.C. § 1326(b)(2) and not a separate criminal offense, and by *United States v. Mares,*402 F.3d 511, 520 (5th Cir.2005), *cert. denied*— U.S. -, — S.Ct. -, — L.Ed.2d -, 2005 WL 816208 (2005), and its progeny, which held that unpreserved claims based on *United States v. Booker,*— U.S. -, 125 S.Ct. 738, 160 L.Ed.2d 621 (2005), are reviewed for plain error. The Government’s motion for summary affirmance is GRANTED, and the judgment of the district court is AFFIRMED.

*

 Pursuant to 5th Cir. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5th Cir. R. 47.5.4.
SERVED DECEMBER 4, 2010 

:EmRTMENTOF 

U.S. DEPARTMENT OF TRANSPORTATION -ANSPORTATIOM 

OFFICE OF HEARINGS ' •' S OPERATIONS 

WASHINGTON, DC 

X ~3 P 2:UR i.'.t 

IN THE MATTER OF 

SKYWEST AIRLINES, INC. 

FAA DOCKET NO. CP09NM0012 

(Civil Penalty Action) 

DMS No. FAA-2009-0979 

POST HEARING BRIEFING SCHEDULE 

This matter came for hearing on December 1 and 2, 2010, in Salt Lake City, UT. 

The hearing transcript is forthcoming. 

WHEREFORE, the parties shall adhere to the following Post Hearing Briefing 

Schedule: 

1. Federal Aviation Administration (hereinafter "Complainant") shall file its 

Post-Hearing Brief on or before January 28, 2011; 

2. SkyWest Airlines, Inc. (hereinafter "Respondent") shall file its PostHearing Brief on or before February 14, 2011; and 

3. Complainant shall file its Rebuttal Brief, if any, on or before February 22, 

2011. 

"^yy^^-^jJ ^^ -

Richard C. Goodwin 

U.S. Administrative Law Judge 

Attachment(s) - Service List 
FAA Docket No. CP09NM0012 

(Civil Penalty Action) 

SERVICE LIST 

ORIGINAL & ONE COPY 

Federal Aviation Administration 

800 Independence Avenue, S.W. 

Washington, DC 20591 

Attention: Hearing Docket Clerk, AGC-430 

Wilbur Wright Building—Suite 2W1000' 

ONE COPY 

Todd C. Emerson, Respondent's Counsel 

Director, Government and Legal Affairs 

SkyWest Airlines 

444 South River Road 

St. George, UT 84790 

TEL: 435-634-3530 

FAX: 435-634-3505 

Scott R. Morris, Complainant's Counsel 

Attorney, Office of the Regional Counsel 

^Torthwest Mountain Region, ANM-7 

Federal Aviation Administration 

1601 Lind Avenue, S.W. 

Renton, WA 98057 

TEL: 425-227-1417 

FAX: 425-227-1007 

The Honorable Richard C. Goodwin, Administrative Law Judge 

Ofifice of Hearings, M-20 

U.S. Department of Transportation 

1200 New Jersey Avenue, S.E. 

East Building Ground Floor, Room El2-320 

Washington, DC 20590 

TEL: 202-366-2139 Attorney-Advisor 

202-366-5121 Legal Assistant 

FAX: 202-366-7536 

' Service was by U.S. Mail. For service in person or by expedited courier, use the following address: 

Federal Aviation Administration, 600 Indqjendence Avenue, S. W., Wilbur Wright Building—Suite 

2W1000, Washington, DC 20591; Attention; Hearing Docket Clerk, AGC-430.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINES SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-K
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          SEP-30-1999
<PERIOD-START>                             OCT-01-1998
<PERIOD-END>                               SEP-30-1999
<CASH>                                          59,497
<SECURITIES>                                         0
<RECEIVABLES>                                  612,520
<ALLOWANCES>                                    27,583
<INVENTORY>                                  1,243,153
<CURRENT-ASSETS>                             1,920,006
<PP&E>                                         134,740
<DEPRECIATION>                                  70,356
<TOTAL-ASSETS>                               2,060,599
<CURRENT-LIABILITIES>                        1,327,283
<BONDS>                                        558,705
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           578
<OTHER-SE>                                     165,699
<TOTAL-LIABILITY-AND-EQUITY>                 2,060,599
<SALES>                                      9,807,363
<TOTAL-REVENUES>                             9,807,363
<CGS>                                        9,334,298
<TOTAL-COSTS>                                9,334,298
<OTHER-EXPENSES>                               314,063
<LOSS-PROVISION>                                 6,956
<INTEREST-EXPENSE>                              39,690
<INCOME-PRETAX>                                119,312
<INCOME-TAX>                                    48,397
<INCOME-CONTINUING>                             70,915
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                  3,449
<CHANGES>                                            0
<NET-INCOME>                                    67,466
<EPS-BASIC>                                       1.33
<EPS-DILUTED>                                     1.31


</TABLE>
[Federal Register Volume 88, Number 239 (Thursday, December 14, 2023)]
[Notices]
[Pages 86662-86663]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-27421]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose

[[Page 86663]]

confidential trade secrets or commercial property such as patentable 
material, and personal information concerning individuals associated 
with the grant applications, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Special Topic: Pain Therapeutics.
    Date: January 5, 2024.
    Time: 12:00 p.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Lai Yee Leung, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 1011D, Bethesda, MD 20892, (301) 827-8106, 
<a href="/cdn-cgi/l/email-protection#e48881918a8388d6a4879796ca8a8d8cca838b92"><span class="__cf_email__" data-cfemail="8ae6efffe4ede6b8cae9f9f8a4e4e3e2a4ede5fc">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: December 8, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-27421 Filed 12-13-23; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
#### Hunter, Appellant, *v.*Hunter.

Argued April 14, 1943.

Before Keller, P. J., Bald-rige, Stadtfeld, Bhodes, Hirt, Kenworthey and Reno, JJ.

*F. Joseph Thomas,*for appellant.

No one appeared or filed a brief for appellee.

*454July 16, 1943:

Opinion by

Kenworthey, J.;

The marriage which this action seeks to dissolve was, in its inception at least, one of convenience. The parties are the parents of a child born out of wedlock in July 1940. They were married the following October “to give the child a name.” They never lived together as man and wife.

The husband brought the action on the ground of desertion. His testimony, which was corroborated and uncontradicted (respondent did not appear), was to the effect that after the marriage on several occasions he asked respondent to come to live with him and make a home, that he was ready and willing to establish a home, •but that respondent refused, saying she did not love him and would not live with him under any circumstances. The truth of this testimony and the bona tides of the offer to establish a home were accepted by the master who recommended that a divorce be granted; it was apparently also accepted by the court below. But the court refused the divorce on the ground that there could be no desertion without there first having been, in fact, a common home. It said: “Both habitation and matrimonial cohabitation are essential elements, the abandonment of which, without cause or consent, constitutes desertion, if persisted in for a period of two years.”

That this conclusion was wrong is indicated by *Spangler v. Spangler,*114 Pa. Superior Ct. 308, 174 A. 588; it gives much too narrow a construction to the language of our divorce law. It would mean that a spouse who wilfully refused cohabitation from the inception of the marriage could forever defeat the right of the injured spouse to a divorce. Such a construction would be wholly unreasonable.

The decree is reversed and the record is remitted to the court below with direction to enter a decree of absolute divorce.
An Equal Opportunity Provider and Employer

CENTER FOR VETERINARY BIOLOGICS NOTICE NO. 20-10

TO: Biologics Licensees, Permittees, and Applicants

 Directors, Center for Veterinary Biologics

 Veterinary Services Leadership Team

FROM: Byron Rippke

 Director

SUBJECT: Certification of Veterinary Vaccines and Immunotherapeutics as 

Containing Genetically Modified Organisms

The purpose of this Notice is to inform interested parties of the Center for Veterinary 

Biologics’ (CVB) policies regarding certification of USDA licensed veterinary 

vaccines and immunotherapeutics as genetically modified organisms (GMO) or nongenetically modified organisms (non-GMO). CVB classifies products derived using 

biotechnological techniques as GMOs. CVB will provide confirmation of the 

presence of Master Seeds or Master Cells used in production that are genetically 

modified using recombinant and/or synthetic nucleic acid molecules, as defined in 

the National Institute of Health’s (NIH) Guidelines for Research Involving 

Recombinant or Synthetic Nucleic Acid Molecules (NIH GUIDELINES, APRIL 

2019): 

Definition of Recombinant and Synthetic Nucleic Acid Molecules

In the context of the NIH Guidelines, recombinant and synthetic nucleic acids are 

defined as:

(i) molecules that a) are constructed by joining nucleic acid molecules and b)

can replicate in a living cell, i.e., recombinant nucleic acids;

(ii) nucleic acid molecules that are chemically or by other means synthesized or 

amplified, including those that are chemically or otherwise modified but can 

base pair with naturally occurring nucleic acid molecules, i.e., synthetic 

nucleic acids, or

(iii) molecules that result from the replication of those described in (i) or (ii) 

above.

CVB will NOT issue certifications/confirmations of a product as “non-GMO” 

because there is no universally accepted definition on which to base such an 

evaluation. No certifications will be issued for in vitro diagnostic products.

Animal and Plant

Health Inspection

Service

Veterinary Services

Center for Veterinary 

Biologics

1920 Dayton Avenue

PO Box 844

Ames, IA 50010

(515) 337-6100
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED CONSOLIDATED BALANCE SHEET AND CONDENSED CONSOLIDATED STATEMENT OF
INCOME AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUN-30-2001
<PERIOD-START>                             JUL-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                           5,938
<SECURITIES>                                         0
<RECEIVABLES>                                   31,856
<ALLOWANCES>                                  (14,926)
<INVENTORY>                                      4,397
<CURRENT-ASSETS>                                42,428
<PP&E>                                         235,315
<DEPRECIATION>                                (97,000)
<TOTAL-ASSETS>                                 220,343
<CURRENT-LIABILITIES>                           72,895
<BONDS>                                         31,225
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           301
<OTHER-SE>                                     115,688
<TOTAL-LIABILITY-AND-EQUITY>                   220,343
<SALES>                                         72,561
<TOTAL-REVENUES>                                72,561
<CGS>                                           53,007
<TOTAL-COSTS>                                   70,050
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                   852
<INTEREST-EXPENSE>                                 615
<INCOME-PRETAX>                                  1,896
<INCOME-TAX>                                       740
<INCOME-CONTINUING>                              1,156
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,156
<EPS-BASIC>                                        .04
<EPS-DILUTED>                                      .04


</TABLE>
EXHIBIT 32.2

CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of E Com Ventures, Inc.
(the Company) on Form 10-Q for the period ending May 5, 2007 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Donovan Chin, Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:



| | 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | -- | ---------------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------



By:

/s/ Donovan ChinDonovan ChinChief Financial OfficerJune 18, 2007
| 1.   | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|----------------|-----------------------------------------------------------------------------------------------------------------------|

| 2.   | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|----------------|------------------------------------------------------------------------------------------------------------------------------------------------------|

| /s/ Clayton W. Williams |
|-------------------------|
| Clayton W. Williams     |
| Chief Executive Officer |
| May 7, 2010             |
|                    |
|                    |
| /s/ Mel G. Riggs        |
| Mel G. Riggs            |
| Chief Financial Officer |
| May 7, 2010             |
##### 



EXHIBIT 32.1 SECTION 1350 CERTIFICATION In connection with the quarterly report of CSB Bancorp, Inc. (the Company) on
Form 10-Q for the three-month period ended March 31, 2004 as filed with the
Securities and Exchange Commission on the date hereof (the Report), I, John
J. Limbert, President and Chief Executive Officer, certify, pursuant to 18
U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley
Act of 2002, that to the best of my knowledge:  (1)
    
    The Report fully complies with the requirements of section
13(a) or 15(d) of the Securities Exchange Act of 1934; and(2)
    
    The information contained in the Report fairly presents, in
all material respects, the financial condition and results of
operations of the Company. Date: May 14, 2004
    
    /s/ John J. Limbert
John J. Limbert
President and
Chief Executive Officer
 *This certification is being furnished as required by Rule 13a-14(b) under the
Securities Exchange Act of 1934 (the Exchange Act) and Section 1350 of
Chapter 63 of Title 18 of the United States Code, and shall not be deemed
filed for purposes of Section 18 of the Exchange Act or otherwise subject to
the liability of that section. This certification shall not be deemed to be
incorporated by reference into any filing under the Securities Act of 1933 or
the Exchange Act, except as otherwise stated in such filing. 21.
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 00-6155

ROBERT WATSON,

Plaintiff - Appellant,

versus

WILLIE WELDON, Warden; STEVE J. LENSES, Doctor,

Defendants - Appellees.

Appeal from the United States District Court for the District of

South Carolina, at Charleston. Cameron McGowan Currie, District

Judge. (CA-99-1006-2-22)

Submitted: June 13, 2000 Decided: July 10, 2000

Before WILKINS, MOTZ, and TRAXLER, Circuit Judges.

Affirmed by unpublished per curiam opinion.

Robert Watson, Appellant Pro Se. Sandra Jane Senn, Charleston,

South Carolina; Jackson L. Barwick, Jr., Columbia, South Carolina,

for Appellees.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

Robert Watson appeals the district court’s order denying relief on his 42 U.S.C.A. § 1983 (West Supp. 2000) complaint. We

have reviewed the record and the district court’s opinion accepting

the magistrate judge’s recommendation and find no reversible error.

Accordingly, we affirm on the reasoning of the district court. See

Watson v. Weldon, No. CA-99-1006-2-22 (D.S.C. Jan. 18, 2000). We

dispense with oral argument because the facts and legal contentions

are adequately presented in the materials before the court and

argument would not aid the decisional process.

AFFIRMED
MEMORANDUM 

DATE: July 30, 2015

TO: Clean Power Plan for Existing Power Plants; Docket Id: OAR–2013-0602

FROM: EPA Region 1

SUBJECT: April 16, 2015, Speech during Environmental Business Council Earth Day Even 

including Proposed Clean Power Plan for Existing Power Plants

SUMMARY

On April 16, 2015, Regional Administrator Curt Spalding spoke at the Environmental 

Business Council’s Earth Day Event. The speech included the proposed Clean Power Plan for 

Existing Power Plants.

ATTENDEES

Curt Spalding, EPA

Approximately 40 people attended this conference. Attendance was not taken by EPA